Boston Scientific Corporation,a global medical technology leader, has completed a first-in-human clinical trial utilizing the IntellaTip MiFi XP Ablation Catheter for the treatment of type 1 atrial ...
In patients with persistent atrial fibrillation, those receiving pulsed field ablation as first-line therapy had less risk ...
NFL players, coaches and staff put their bodies on the line every season. They sacrifice health, time, energy and more for a chance to win a Super Bowl. When that season eventually comes to an end, it ...
Emerging pulsed field ablation systems had their moments in the spotlight at the annual meeting of the Heart Rhythm Society (HRS), being held in San Diego this weekend. The therapy has made a major ...
Twelve-month data from the VOLT-AF Global IDE study found that the Volt PFA System had an industry-leading success rate (84.2%) of freedom from documented rhythm recurrence among all competitive PFA ...
Vektor Medical to Showcase VITAL-EP Registry’s Atrial Fibrillation Results, Including Fast, Zero-Fluoro PVI+ Ablation Workflow, and New Atrial Flutter Capabilities Visit Vektor Medical at Booth 208 to ...
Guidelines recommend a trial of antiarrhythmic drugs before catheter ablation for persistent atrial fibrillation. Whether pulsed field ablation (PFA) may be a preferred initial treatment is ...
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, ...
Kardium has collected an FDA approval for its pulsed field ablation approach to treating atrial fibrillation, giving it the go-ahead to compete in the emerging sector against heavyweights such as ...
BOSTON--(BUSINESS WIRE)--Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5–8 in Boston, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results